相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
Harry Levine
PROTEIN SCIENCE (2010)
The effect of serum withdrawal on the protein profile of quiescent human dermal fibroblasts in primary cell culture
Federica Boraldi et al.
PROTEOMICS (2008)
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production
Tae Woo Jung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Amisulpride-induced tardive dyskinesia
Konstantinos N. Fountoulakis et al.
SCHIZOPHRENIA RESEARCH (2006)
Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled clinical trial
Pierre N. Tariot et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on β-amyloid and α-synuclein
Brian J. Tabner et al.
FREE RADICAL RESEARCH (2006)
The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice
M Asai et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Olanzapine and quetiapine protect PC12 cells from β-amyloid peptide25-35-induced oxidative stress and the ensuing apoptosis.
HT Wang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Oxidative stress potentiates BACE1 gene expression and Aβ generation
Y Tong et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Oxidative stress during treatment with first- and second-generation antipsychotics
S Kropp et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2005)
Effects of quetiapine on cognitive functions in schizophrenia
BBK Akdede et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study
R Karry et al.
BIOLOGICAL PSYCHIATRY (2004)
Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients
R Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Atypical antipsychotic drugs and tardive dyskinesia:: relevance of D2 receptor affinity
RA Bressan et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease
HM Abdul et al.
NEUROSCIENCE LETTERS (2004)
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease
JL Juncos et al.
MOVEMENT DISORDERS (2004)
Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type
T Fujikawa et al.
NEUROPSYCHOBIOLOGY (2004)
Quetiapine - A review of its use in the management of schizophrenia
SM Cheer et al.
CNS DRUGS (2004)
Atypical antipsychotics attenuate neurotoxicity of β-amyloid(25-35) by modulating Bax and Bcl-XL/S expression and localization
ZL Wei et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis
H Qing et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
LB Yang et al.
NATURE MEDICINE (2003)
Role of oxidative stress and antioxidants in neurodegenerative diseases
AV Rao et al.
NUTRITIONAL NEUROSCIENCE (2002)
Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal
O Bai et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease
BJ Tabner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance
Ö Akyol et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Cognitive and behavioral effects of quetiapine in Alzheimer disease patients
DW Scharre et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2002)
Interaction between synthetic amyloid-β-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry
Z Skribanek et al.
JOURNAL OF MASS SPECTROMETRY (2001)
Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ(25-35)
S Varadarajan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Oxidative damage and schizophrenia - An overview of the evidence and its therapeutic implications
JK Yao et al.
CNS DRUGS (2001)
Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine
C Vesely et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2000)
分享论文
